Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
120 participants
INTERVENTIONAL
2025-10-15
2026-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question that the study is designed to answer is:
Compared to written information alone, does the addition on a short animated introductory film reduce decisional conflict for expectant women regarding the use of epidural pain relief.
Secondary outcomes tested will be change in anxiety and satisfaction scores after receiving the information.
Study participants will include women expecting their first baby, presenting to hospital for induction of labour. They will be asked to fill out a questionnaire regarding thoughts and feelings around epidural, before and after receiving information about the procedure. Participants will be randomised to receive either traditional written information alone or with the addition of the animated film.
A smaller number of participants will also be asked to participate in a short interview about the animated film.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Levobupivacaine for Epidural Analgesia in Labour
NCT00929682
3 Simple Questions to Predict Labor Pain and Epidural Analgesia Use in Parturients
NCT02824302
Impact of Timing of Neuraxial Analgesia on Obstetric, Anesthesiologic and Neonatal Outcomes in Induced Labour
NCT06886555
Compared Efficacy of Patient-controlled Epidural Analgesia With or Without Automatic Boluses
NCT03407209
Comparison of Epidural Labor Pain Relief Techniques on Maternal and Fetal Outcomes
NCT02008591
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The planned sample size is 60 in control group, 60 in intervention group (120 in total). The study will only involve primiparous women presenting to the antenatal ward for induction of labour.
Participation in the study will take place on the antenatal unit, before transfer to labour ward. Participants will be asked to complete a pre-intervention survey regarding decisional conflict score for labour analgesia choices and including Likert scales for anxiety and understanding related to epidural.
They will then be given information about epidural for labour analgesia - the control group will receive written information alone; the intervention group will watch a short animation introducing the concept of epidural, followed by the same written information.
This will be followed by a post-intervention survey. A smaller group will be selected (dependent on availability of interviewer) for a short interview to allow qualitative analysis of the acceptability and effectiveness of the animation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Participant receives written information about epidural alone
Participant receives current gold standard written information alone
Gold standard OAA (Obstetric Anaesthetists' Association) epidural information card
Intervention group
Participant receives animated introductory film in addition to written information about epidural
Participant views Epidural animation before reading gold standard written information
Addition of introductory animation to written OAA epidural information card about labour epidural
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Participant views Epidural animation before reading gold standard written information
Addition of introductory animation to written OAA epidural information card about labour epidural
Participant receives current gold standard written information alone
Gold standard OAA (Obstetric Anaesthetists' Association) epidural information card
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Unable to speak English or any of the seven language translations provided
* Epidural contraindicated
* Previous Epidural for any reason
* Any significant health concerns
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College London
OTHER
University of Oxford
OTHER
Chelsea and Westminster NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charles Prior, FRCA
Role: PRINCIPAL_INVESTIGATOR
Chelsea & Westminster NHS Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
West Middlesex Hospital, Chelsea & Westminster NHS Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Philip Barclay, FRCA
Role: CONTACT
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
351150
Identifier Type: OTHER
Identifier Source: secondary_id
351150-SALE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.